Nikola signs memorandum of understanding with General Motors

[ad_1] PHOENIX, November 30, 2020 / PRNewswire / – Nikola Corporation (NASDAQ: NKLA) today announced the signing of a non-binding Memorandum of Understanding (“MOU”) with General Motors for a global supply agreement related to the integration of the GM’s Hydrotec fuel cell in Nikola commercial semi-trucks. This replaces and replaces the transaction announced on September … Read more

How NIO, a Chinese electric vehicle start-up, has grown again

[ad_1] SHANGHAI – A year ago, Chinese electric vehicle start-up NIO Inc. was almost in ruins. Today it is worth more than General Motors Co. NIO’s pinch with bankruptcy and its subsequent rebirth to become the world’s fourth most valuable automaker – only Tesla Inc., Toyota Motor Corp. and Volkswagen AG are worth more in … Read more

Nikola shares drop after GM abandons stake in reworked smaller deal

[ad_1] CEO and Founder of the US Nikola Trevor Milton Massimo Pinca | Reuters General Motors is giving up a potential 11% stake in Nikola and is abandoning plans to build electric truck maker Badger’s pickup as part of a smaller and reworked deal, the companies said on Monday. In September, automakers announced a $ … Read more

Congress under pressure to adopt COVID-19 stimulus, has brief window

[ad_1] Monday is the start of a new and brief session of Congress in which they could pass a new coronavirus stimulus bill. President Trump and President-elect Biden have said they want Congress to strike a deal. But for months Democrats and Republicans argued over the details of the funding programs – ranging from $ … Read more

Why Novavax could be a bigger COVID vaccine winner than Pfizer and Moderna

[ad_1] Some Americans could receive COVID-19 vaccines before the end of 2020. Two coronavirus vaccines are in a privileged position to obtain US Emergency Use Authorization (EUA) next month – Pfizerof (NYSE: PFE) and BioNTechof (NASDAQ: BNTX) BNT162b2 and Modernof (NASDAQ: ARNM) MRNA-1273. Novavax (NASDAQ: NVAX) is lagging behind with its experimental vaccine candidate against … Read more